100 related articles for article (PubMed ID: 20813419)
1. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells.
Fillebeen C; Pantopoulos K
J Hepatol; 2010 Dec; 53(6):995-9. PubMed ID: 20813419
[TBL] [Abstract][Full Text] [Related]
2. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
3. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.
Fillebeen C; Muckenthaler M; Andriopoulos B; Bisaillon M; Mounir Z; Hentze MW; Koromilas AE; Pantopoulos K
J Hepatol; 2007 Jul; 47(1):12-22. PubMed ID: 17399844
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
[TBL] [Abstract][Full Text] [Related]
6. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
7. Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives.
Salim MT; Aoyama H; Sugita K; Watashi K; Wakita T; Hamasaki T; Okamoto M; Urata Y; Hashimoto Y; Baba M
Biochem Biophys Res Commun; 2011 Dec; 415(4):714-9. PubMed ID: 22085716
[TBL] [Abstract][Full Text] [Related]
8. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
9. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
10. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
González-Carmona MA; Vogt A; Heinicke T; Quasdorff M; Hoffmann P; Yildiz Y; Schneider C; Serwe M; Bartenschlager R; Sauerbruch T; Caselmann WH
J Hepatol; 2011 Jul; 55(1):19-28. PubMed ID: 21145870
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
[TBL] [Abstract][Full Text] [Related]
13. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
14. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
16. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
[TBL] [Abstract][Full Text] [Related]
17. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.
Fillebeen C; Rivas-Estilla AM; Bisaillon M; Ponka P; Muckenthaler M; Hentze MW; Koromilas AE; Pantopoulos K
J Biol Chem; 2005 Mar; 280(10):9049-57. PubMed ID: 15637067
[TBL] [Abstract][Full Text] [Related]
18. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
19. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1.
Satoh M; Saito M; Takano T; Kasama Y; Nishimura T; Nishito Y; Hirata Y; Arai M; Sudoh M; Kai C; Kohara M; Tsukiyama-Kohara K
J Infect Dis; 2011 Oct; 204(8):1172-80. PubMed ID: 21917889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
